|
Number
|
48
|
22 (1–10 mm, 4.16 ± 2.82 mm)
|
70
|
NS
|
|
Gender
| | | | |
|
Male
|
37 (77.1)
|
13 (59.1)
|
50 (71.4)
|
NS
|
|
Female
|
11 (22.9)
|
9 (40.9)
|
20 (28.6)
| |
|
M/F ratio
|
3.36
|
1.44
|
2.50
| |
|
Age (year)
| | | | |
|
≤ 40
|
0 (0)
|
0
|
0
|
NS
|
|
41–69
|
35 (72.9)
|
19 (86.4)
|
54 (77.1)
| |
|
≥ 70
|
13 (27.1)
|
3 (13.6)
|
16 (22.9)
| |
|
Average (SD)
|
64.44 ± 7.57
|
63.14 ± 7.88
|
64.03 ± 7.63
|
NS
|
|
Origin
| | | | |
|
Gastric
|
48 (100)
|
22 (100)
|
70 (100)
|
NS
|
|
Oesophagus
|
0 (0)
|
0 (0)
|
0 (0)
| |
|
Metaplasia
| | | | |
|
Without
|
14 (29.2)
|
6 (27.3))
|
20 (28.6)
|
NS
|
|
Columnar cell
|
23 (47.9)
|
11 (50.0)
|
34 (48.6)
| |
|
Pancreatic
|
10 (20.8)
|
3 (13.6)
|
13 (18.6)
| |
|
Goblet cell
|
1 (2.1)
|
2 (9.1)
|
3 (4.3)
| |
|
Macroscopic feature
| | | | |
|
I
|
3 (6.3)
|
2 (9.1)
|
5 (7.1)
|
NS
|
|
IIa
|
2 (4.2)
|
0 (0)
|
2 (2.9)
| |
|
IIb
|
10 (20.8)
|
6 (27.3)
|
16 (22.9)
| |
|
IIc
|
17 (35.4)
|
6 (27.3)
|
23 (32.9)
| |
|
III
|
16 (33.3)
|
8 (36.4)
|
24 (34.3)
| |
|
I + IIa
|
5 (10.4)
|
2 (9.1)
|
7 (10.0)
|
NS
|
|
IIb
|
10 (20.8)
|
6 (27.3)
|
16 (22.9)
| |
|
IIc + III
|
33 (68.8)31
|
14 (63.6)
|
47 (67.1)
| |
|
Size (cm)
| | | | |
|
≤ 0.9
|
10 (20.8)
|
2 (9.1)
|
12 (17.1)
|
NS
|
|
1–1.9
|
21 (43.8)
|
5 (22.7)
|
26 (37.1)
| |
|
2–2.9
|
12 (25.0)
|
8 (36.4)
|
20 (28.6)
| |
|
> 3
|
5 (10.4)
|
7 (31.8)
|
12 (17.1)
| |
|
Invasion depth
| | | | |
|
M2
|
7 (14.6)
|
2 (9.1)
|
9 (12.9))
|
NS
|
|
M3
|
14 (29.2)
|
5 (22.7)
|
19 (27.1)
| |
|
SM1
|
7 (14.6)
|
3 (13.6)
|
10 (14.3)
| |
|
SM2
|
20 (41.7)
|
12 (54.5)
|
32 (45.7)
| |
|
Histology type
| | | | |
|
Tubular adenocarcinoma
|
32 (66.7)
|
8 (36.4)
|
40 (57.1)
|
< 0.05
|
|
Papillary adenocarcinoma
|
7 (14.6)
|
6 (27.3)
|
13 (18.6)
| |
|
Micropapillary adenocarcinomaa
|
1 (2.1)
|
0 (0)
|
1 (1.4)
| |
|
Poorly cohesive carcinoma
|
1 (2.1)
|
1 (4.5)
|
2 (2.8)
| |
|
Mucinous carcinoma
|
1 (2.1)
|
0 (0)
|
1 (1.4)
| |
|
Mixed PCC and adenocarcinoma
|
3 (6.3)
|
3 (13.6)
|
6 (8.6)
| |
|
Mixed mucinous and tubular adenocarcinoma
|
1 (2.1)
|
2 (9.1)
|
3 (4.3)
| |
|
Neuroendocrine/medullary /adenosquamous/clear cell carcinoma
|
2 (4.2)
|
2 (9.1)
|
4 (5.7)
| |
|
Differentiation
| | | | |
|
Well
|
13 (27.1)
|
4 (18.2)
|
17 (24.3)
|
NS
|
|
Moderate
|
28 (58.3)
|
14 (63.6)
|
42 (60.0)
| |
|
Poorly
|
7 (14.6)
|
4 (18.2)
|
11 (15.7)
| |
|
Lymphovascular invasion
| | | | |
|
Absence
|
42 (87.5)
|
17 (77.3)
|
59 (84.3)
|
NS
|
|
Presence
|
6 (12.5)
|
5 (22.7)
|
11 (15.7)
| |
|
Perineural invasion
| | | | |
|
Absence
|
46 (95.8)
|
21 (95.5)
|
67 (95.7)
|
NS
|
|
Presence
|
2 (4.2)
|
1 (4.5)
|
3 (4.3)
| |
|
Lymph node metastasis
| | | | |
|
Absence
|
43 (89.6)
|
20 (90.9)
|
63 (90.0)
|
NS
|
|
Presence
|
5 (10.4))
|
2 (9.1)
|
7 (10.0)
| |
|
N1
|
4 (8.3)
|
1 (4.5)
|
5 (7.1)
| |
|
N2
|
1 (2.1)
|
0 (0)
|
1 (1.4)
| |
|
N3
|
0 (0.0)
|
1 (4.5)
|
1 (1.4)
| |
